Goldman Sachs Has Potential For Significant Alpha Generation: Analyst
Goldman Sachs has a Buy rating and price target of $525; Shares declined by 0.9% to $452.47 at last check on Monday.
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
Discover the results of Ionis Pharmaceuticals' Phase 3 studies on donidalorsen for hereditary angioedema. FDA application submission expected this year.
AMD, TSMC, Broadcom And Other Chip Stocks Hit By Biden’s Fresh AI Chip Export Restrictions: Details
Embargo on AI chip exports to Middle East triggers selloff in broader sector, including NVDA and AMD. Chip CEOs discuss AI at Taiwan's Computex.
Best Buy To Stabilize Despite A Soft Q1, Analysts Say
Goldman Sachs analyst Kate McShane noted BBY reported better-than-expected Q1 results and provided guidance that still suggests a potential top-line recovery in the second half of the year.
Costco ‘Firing On All Cylinders’: 6 Analysts Size Up Q3, Catalysts Of ‘Membership Fee Hike And Stock Split’
Analysts see Costco as a strong performer and market share taker in the retail space after third-quarter (Q3) results.
Cautious Optimism Surrounds Dollar General’s FY24: Analysts Highlight Strategic Gains Amid Emerging Risks
Truist Securities has reiterated its Hold rating for Dollar General, lowering the price target from $140 to $135. Analyst Scot Ciccarelli notes better-than-expected comparable sales but expects a backend-loaded year, adjusting 2024/2025 estimates to $7.30/$8.05 from $7.35/$8.20. Despite 4% traffic growth, shopping behaviors reflect a stressed customer base.
Cybersecurity Stock Zscaler’s Impressive Q3 Print And Federal Expansion Boost Analyst Confidence
Zscaler reported better-than-expected Q3 earnings and lower price targets, but analysts remain optimistic for long-term growth potential.
Ulta Beauty To Recover In Second Half Of 2024: 8 Analysts Dissect Q1 Results
Ulta Beauty's Q1 results beat expectations, but lowered guidance due to competitive pressure. Some analysts have revised forecasts.
Marvell Technology’s Revenues To Recover On AI Demand; These 9 Analysts Dive Into Q1 Results
Marvell Technology stock drops after Q1 earnings miss. The company's revenues are expected to ramp in 2H, driven by demand for AI infrastructure.
$5 Meal Frenzy Not Enough? Why This Analyst Sees Appetite for McDonald’s Stock Despite Value War
"Today's value push is seemingly born out of necessity following year of inflationary pressure that is increasingly weighing on cost-conscious consumers," KeyBanc said.